Cite
Pioglitazone Improved Insulin Sensitivity and First Phase Insulin Secretion Among Obese and Lean People with Diabetes: A Multicenter Clamp Study.
MLA
Xin Qian, et al. “Pioglitazone Improved Insulin Sensitivity and First Phase Insulin Secretion Among Obese and Lean People with Diabetes: A Multicenter Clamp Study.” Diabetes Therapy, vol. 9, no. 2, Apr. 2018, pp. 815–26. EBSCOhost, https://doi.org/10.1007/s13300-018-0401-9.
APA
Xin Qian, Hui Wang, Gangyi Yang, Zhengnan Gao, Yong Luo, Aimei Dong, Fang Zhang, Mingtong Xu, Shiping Liu, Xin Yang, Yanyan Chen, & Guangwei Li. (2018). Pioglitazone Improved Insulin Sensitivity and First Phase Insulin Secretion Among Obese and Lean People with Diabetes: A Multicenter Clamp Study. Diabetes Therapy, 9(2), 815–826. https://doi.org/10.1007/s13300-018-0401-9
Chicago
Xin Qian, Hui Wang, Gangyi Yang, Zhengnan Gao, Yong Luo, Aimei Dong, Fang Zhang, et al. 2018. “Pioglitazone Improved Insulin Sensitivity and First Phase Insulin Secretion Among Obese and Lean People with Diabetes: A Multicenter Clamp Study.” Diabetes Therapy 9 (2): 815–26. doi:10.1007/s13300-018-0401-9.